{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T22:06:11Z","timestamp":1764540371101,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["FWO - 1S90621N"],"award-info":[{"award-number":["FWO - 1S90621N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.prp.2022.153772","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:29:49Z","timestamp":1642598989000},"page":"153772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!"],"prefix":"10.1016","volume":"231","author":[{"given":"Fleur","family":"Cordier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joni","family":"Van der Meulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"van Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilke","family":"De Wilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"van Dijck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Vanhoenacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Lambrechts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Noyez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Van de Vijver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Ferdinande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Dendooven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Van Dorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Creytens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153772_bib1","unstructured":"WHO classification of thoracic tumors, 5th edition 2021."},{"issue":"2","key":"10.1016\/j.prp.2022.153772_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK rearrangements in malignant Peritoneal Mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol."},{"issue":"29","key":"10.1016\/j.prp.2022.153772_bib3","doi-asserted-by":"crossref","first-page":"20781","DOI":"10.18632\/oncotarget.25111","article-title":"A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy","volume":"9","author":"M\u00f6nch","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2022.153772_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41379-019-0330-9","article-title":"Molecular characterization of localized pleural mesothelioma","volume":"33","author":"Hung","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2022.153772_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2020.05.019","article-title":"and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer","volume":"146","author":"Leal","year":"2020","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.prp.2022.153772_bib6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural Mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.prp.2022.153772_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2022.153772_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/modpathol.2017.181","article-title":"Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer","volume":"31","author":"Rosenbaum","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2022.153772_bib9","doi-asserted-by":"crossref","unstructured":"J. Andrici, T.R. Parkhill, J. Jung, K.L. Wardell, B. Verdonk, A. Singh, L. Sioson, A. Clarkson, N. Watson, A. Sheen, M. Farzin, C.W. Toon, A.J. Gill, Loss of expression of BAP1 is very rare in non-small cell lung carcinoma. Pathology. 2016 Jun;48(4):336\u2013340. doi: 10.1016\/j.pathol.2016.03.005. Epub 2016 Apr 21. PMID: 27114369.","DOI":"10.1016\/j.pathol.2016.03.005"},{"key":"10.1016\/j.prp.2022.153772_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/10668969211070179","article-title":"Somatic mutation of BAP1 can lead to expression loss in non-small cell lung carcinoma: next generation sequencing and IHC analysis in a large single institute cohort","author":"Sun","year":"2022","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153772_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000109618","article-title":"Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH","volume":"119","author":"Lindhom","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.prp.2022.153772_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2016.04.015","article-title":"Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array","volume":"55","author":"Chirac","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2022.153772_bib13","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1612074113","article-title":"High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma","volume":"113","author":"Yoshikawa","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.prp.2022.153772_bib14","doi-asserted-by":"crossref","first-page":"E1487","DOI":"10.21037\/jtd.2016.11.58","article-title":"The use of electron microscopy for the diagnosis of malignant pleural mesothelioma","volume":"8","author":"Ferlosio","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.prp.2022.153772_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/01913120500313143","article-title":"Macroscopic, histologic, histochemical, immunohistochemical, and ultrastructural features of mesothelioma","volume":"30","author":"Hammar","year":"2006","journal-title":"Ultra Pathol."},{"key":"10.1016\/j.prp.2022.153772_bib16","first-page":"1","article-title":"Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study","author":"Van Paemel","year":"2020","journal-title":"Epigenetics"},{"key":"10.1016\/j.prp.2022.153772_bib17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","article-title":"Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications","volume":"27","author":"Krueger","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2022.153772_bib18","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.prp.2022.153772_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/onco.13714","article-title":"A novel malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: a case report and literature review","volume":"26","author":"Miyagawa","year":"2021","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.prp.2022.153772_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jtho.2019.11.011","article-title":"Anaplastic lymphoma kinase gene rearrangement in children and young adults With Mesothelioma","volume":"15","author":"Mian","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2022.153772_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/his.12779","article-title":"Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum","volume":"68","author":"Loharamtaweethong","year":"2016","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.prp.2022.153772_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/PAS.0000000000001656","article-title":"Pediatric Mesothelioma with ALK Fusions: a molecular and pathologic study of 5 cases","volume":"45","author":"Argani","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153772_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lungcan.2020.02.006","article-title":"Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement","volume":"142","author":"Bronte","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2022.153772_bib24","first-page":"00048","article-title":"STRN-ALK rearranged malignant Peritoneal Mesothelioma with dramatic response following ceritinib treatment","volume":"19","author":"R\u00fcschoff","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.prp.2022.153772_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejca.2020.09.011","article-title":"Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution","volume":"140","author":"Orbach","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2022.153772_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13073-019-0631-0","article-title":"Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma","volume":"11","author":"Ladanyi","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.prp.2022.153772_bib27","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1038\/onc.2015.38","article-title":"DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2","volume":"34","author":"Poirier","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.153772_bib28","doi-asserted-by":"crossref","first-page":"E5503","DOI":"10.1073\/pnas.1508736112","article-title":"Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments","volume":"112","author":"Sun","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:47:30Z","timestamp":1759733250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"alternative-id":["S0344033822000152"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153772","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153772"}}